- ISIN
- US82937K1016
- Sector
- Healthcare
- Industry
- Medical Distribution
Highlights
- Market Cap
- $6.51B
- Enterprise Value
- $28.61B
- EPS (TTM)
- CN¥22.66
- PE Ratio
- 3.11
- Total Revenue (TTM)
- CN¥1.15T
- Gross Profit (TTM)
- CN¥85.73B
- EBITDA (TTM)
- CN¥41.17B
- Year Range
- $10.26 - $14.87
- ROA (TTM)
- 3.62%
- ROE (TTM)
- 16.82%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SHTDY Performance Chart
SINOPHARM GROUP CO LTD ADR (SHTDY) is down 15.9% since the beginning of the year. At $10 per share, SHTDY is trading 29.9% below its 52-week high of $15. Investors who bought $1,000 worth of SHTDY shares 5 years ago would now be looking at an investment worth $821.
Loading charts...
Returns By Period
SINOPHARM GROUP CO LTD ADR (SHTDY) has returned -15.89% so far this year and -10.47% over the past 12 months. Over the last ten years, SHTDY has returned -4.66% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
SINOPHARM GROUP CO LTD ADR
- 1D
- -3.25%
- 1M
- -6.79%
- YTD
- -15.89%
- 6M
- -17.29%
- 1Y
- -10.47%
- 3Y*
- -8.81%
- 5Y*
- -3.86%
- 10Y*
- -4.66%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SHTDY Monthly Returns History
Based on dividend-adjusted daily data since Apr 1, 2016, SHTDY's average daily return is +0.01%, while the average monthly return is +0.05%. At this rate, an investment would double in approximately 115.6 years.
Historically, 51% of months were positive and 49% were negative. The best month was Apr 2021 with a return of +26.8%, while the worst month was Mar 2020 at -28.4%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.
On a daily basis, SHTDY closed higher 45% of trading days. The best single day was May 2, 2016 with a return of +14.3%, while the worst single day was Apr 11, 2018 at -16.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.26% | 1.95% | -4.25% | -8.81% | -9.38% | -2.80% | -15.89% | ||||||
| 2025 | -2.43% | -7.48% | -5.59% | 1.17% | 2.74% | 1.06% | 1.67% | 0.84% | -2.01% | 6.05% | 3.05% | -3.28% | -4.92% |
| 2024 | 0.69% | 5.82% | -8.02% | -1.95% | 8.29% | 1.87% | -12.24% | -0.59% | 13.55% | -5.19% | 8.90% | 0.29% | 8.73% |
| 2023 | -3.42% | 9.91% | 11.41% | 17.60% | -6.74% | -1.33% | 0.76% | -7.64% | 0.35% | -18.39% | 3.88% | 6.01% | 7.40% |
| 2022 | 4.35% | 7.71% | -7.04% | 0.44% | 8.07% | 3.53% | -5.22% | -3.32% | -10.48% | -4.74% | 25.32% | 6.42% | 22.37% |
| 2021 | 2.76% | -3.42% | 2.70% | 26.83% | 7.63% | -8.02% | -12.21% | -2.60% | 2.10% | -9.12% | -8.79% | 0.19% | -7.22% |
Benchmark Metrics
SINOPHARM GROUP CO LTD ADR has an annualized alpha of -4.69%, beta of 0.47, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since April 01, 2016.
- This stock participated in 80.79% of S&P 500 Index downside but only 22.49% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.47 may look defensive, but with R2 of 0.06 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -4.69%
- Beta
- 0.47
- R²
- 0.06
- Upside Capture
- 22.49%
- Downside Capture
- 80.79%
Return for Risk
Risk / Return Rank
SHTDY ranks 21 for risk / return — below 21% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for SINOPHARM GROUP CO LTD ADR (SHTDY) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SHTDY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.51 | ||
| Sortino ratioReturn per unit of downside risk | -3.31 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.37 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.41 | 2.78 | -3.19 |
| Martin ratioReturn relative to average drawdown | -1.13 | 12.44 | -13.57 |
Dividends
Dividend History
SINOPHARM GROUP CO LTD ADR provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.47 | $0.60 | $0.60 | $0.59 | $0.43 | $0.33 | $0.35 | $0.36 | $0.29 | $0.59 |
Dividend yield | 0.00% | 3.80% | 4.43% | 4.57% | 4.68% | 3.95% | 2.79% | 1.91% | 1.74% | 1.32% | 2.86% |
Monthly Dividends
The table displays the monthly dividend distributions for SINOPHARM GROUP CO LTD ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.43 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the SINOPHARM GROUP CO LTD ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SINOPHARM GROUP CO LTD ADR was 64.71%, occurring on Mar 19, 2020. The portfolio has not yet recovered.
The current SINOPHARM GROUP CO LTD ADR drawdown is 53.44%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -64.71%Mar 2020 | 1y 11mo | — | 8y 2moApr 2018 - now |
2017 bear market2017 | -27.56%Dec 2017 | 1y 3mo | 3mo 27d | 1y 7moAug 2016 - Apr 2018 |
2016 correction2016 | -15.84%Apr 2016 | 0s | 10d | 10dApr 2016 - May 2016 |
2016 pullback2016 | -6.87%May 2016 | 2d | 20d | 22dMay 2016 - Jun 2016 |
2016 pullback2016 | -5.82%May 2016 | 0s | 5d | 5dMay 2016 - May 2016 |
Drawdown Indicators
| SHTDY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.71% | -56.78% | -7.93% |
Max Drawdown (1Y)Largest decline over 1 year | -25.84% | -9.10% | -16.74% |
Max Drawdown (3Y)Largest decline over 3 years | -32.12% | -18.90% | -13.22% |
Max Drawdown (5Y)Largest decline over 5 years | -37.78% | -25.43% | -12.35% |
Max Drawdown (10Y)Largest decline over 10 years | -64.71% | -33.92% | -30.79% |
Current DrawdownCurrent decline from peak | -53.44% | -1.80% | -51.64% |
Average DrawdownAverage peak-to-trough decline | -37.97% | -10.71% | -27.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.32% | 2.03% | +7.29% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of SINOPHARM GROUP CO LTD ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how SINOPHARM GROUP CO LTD ADR is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for SHTDY, comparing it with other companies in the Medical Distribution industry. Currently, SHTDY has a P/E ratio of 3.1. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SHTDY relative to other companies in the Medical Distribution industry. Currently, SHTDY has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SHTDY in comparison with other companies in the Medical Distribution industry. Currently, SHTDY has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SHTDY
Add SINOPHARM GROUP CO LTD ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SHTDY